Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zeria Pharmaceutical is a leading Japanese pharmaceutical company specializing in the research, development, manufacturing, and distribution of innovative medicines. Its core competencies lie in therapeutic areas such as gastrointestinal diseases, dermatological conditions, and bone and joint disorders, including arthritis and osteoporosis. The company is committed to improving patient health globally.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zeria Pharmaceutical is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Zeria Pharmaceutical last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 19.65 JPY.
Across its last 4 earnings reports, Zeria Pharmaceutical stock moved by ±0.8% on average the following day. The largest reaction was -1.3% on 11/04/2025; 3 of 4 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.